Novadaq Technologies Inc.  

(Public, NASDAQ:NVDQ)   Watch this stock  
Find more results for NVDQ
+0.13 (1.81%)
Real-time:   1:21PM EST
NASDAQ real-time data - Disclaimer
Currency in USD
Range 7.08 - 7.32
52 week 6.00 - 13.22
Open 7.13
Vol / Avg. 131,248.00/660,145.00
Mkt cap 411.88M
P/E     -
Div/yield     -
EPS -0.77
Shares 57.45M
Beta 1.05
Inst. own     -
Jan 11, 2017
Novadaq Technologies Inc at JPMorgan Healthcare Conference
Nov 30, 2016
Novadaq Technologies Inc at Piper Jaffray Healthcare Conference
More events from DailyFinance »    


5090 Explorer Dr Suite 202
+1-905-6293822 (Phone)
+1-905-6290282 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Novadaq Technologies Inc. is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed. The Company's segment is medical devices. The Company's SPY fluorescence imaging technology platform (SPY Fluorescence Imaging) provides clinically relevant anatomic and physiologic images of blood flow in vessels and micro-vessels during a range of surgical and outpatient procedures performed in the operating room or clinic. The Company's products include SPY, SPY Elite, LUNA and PINPOINT Imaging Systems, SPY Analysis Toolkit, DermACELL and SPY-Q Case Manager. DermACELL is an Acellular Dermal Matrix (ADM) that is used in breast reconstruction surgeries, as well as in the treatment of diabetic foot and venous stasis ulcers, and chronic non-healing wounds.

Officers and directors

William A. MacKinnon Chairman of the Board
Age: 69
Bio & Compensation  - Reuters
Rick Mangat Ph.D. President, Chief Executive Officer
Bio & Compensation  - Reuters
Roger Deck Chief Financial Officer
Bio & Compensation  - Reuters
Lori Swalm Vice President of Marketing
Bio & Compensation  - Reuters
Derrick Guo General Counsel, Corporate Secretary
Bio & Compensation  - Reuters
Anthony F. Griffiths Lead Independent Director
Age: 85
Bio & Compensation  - Reuters
Lisa N. Colleran Director
Age: 54
Bio & Compensation  - Reuters
Karen A. Licitra Director
Bio & Compensation  - Reuters
Patrice E. Merrin Independent Director
Age: 67
Bio & Compensation  - Reuters
Thomas G. Wellner Independent Director
Age: 51
Bio & Compensation  - Reuters